Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

February 6, 2007

Study Completion Date

May 19, 2010

Conditions
Polycythemia VeraEssential ThrombocytosisIdiopathic MyelofibrosisNeutrophilsChronic Myeloproliferative Disorders
Trial Locations (2)

20422

VA Medical Center, Washington D.C., Washington D.C.

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00433862 - Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders | Biotech Hunter | Biotech Hunter